FDA Inspection 1086144 — Reproductive Medicine Associates Of Philadelphia, P.c.
The FDA completed an inspection of Reproductive Medicine Associates Of Philadelphia, P.c. on March 22, 2019 in Langhorne, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 22, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Langhorne, PA (United States)